Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top branded biologic drugs in the U.S. that will go generic by 2028

Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*

by Statista Research Department, last edited Feb 1, 2016
Top branded biologic drugs in the U.S. that will go generic by 2028 This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.
Show more

Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
U.S. pharmaceutical industry
U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars"
  • Global overview
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.